Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2154148 | Nuclear Medicine and Biology | 2012 | 7 Pages |
IntroductionHematoporphyrin (Hp) and hematoporphyrin derivatives (HpDs) have been widely used as photosensitizers in photodynamic therapy (PDT). Radiolabeling of HpDs is helpful for preclinical and clinical studies of PDT.MethodsThe histidine-coupled hematoporphyrin (His-Hp) was synthesized and radiolabeled with [99mTc(CO)3(H2O)3]+. Biodistribution of the radioligand and fluorescent imaging of His-Hp in mice bearing S180 tumor were investigated.Results[99mTc(CO)3]+-labeled His-Hp was electrically neutral, hydrophilic and stable. The biodistribution of the radioligand in S180 tumor-bearing mice was similar with that of nonlabeled HpD in the literature. The uptake of His-Hp in tumors and livers was confirmed by fluorescent imaging.ConclusionsThe complex [99mTc(CO)3]+–His-Hp might be suitable for in vivo dose evaluation of HpD in PDT.